NORC at the University of Chicago
6
1
1
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
1 terminated/withdrawn out of 6 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
Role: collaborator
Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central US
Role: collaborator
Michigan SPARC Trial
Role: collaborator
Evaluation of the Health and Economic Consequences of Kentucky's Section 1115 Demonstration Waiver
Role: collaborator
Dating Matters: Strategies to Promote Healthy Teen Relationships
Role: collaborator
Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C
Role: collaborator
All 6 trials loaded